IP Library Granted Patent US 7,202,332
Granted Patent B2
US 7,202,332 · App. 11/128,722 · Granted Apr 10, 2007

Methods for preparing internally constrained peptides and peptidomimetics

Assignee: New York University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,202,332
App. No.
11/128,722
Granted
Apr 10, 2007
Kind
B2
Abstract

The present invention relates to a method for preparing a peptide having a stable, internally constrained alpha-helical, beta-sheet/beta-turn, 3 10 -helical, or pi-helical region and a method of stabilizing an alpha-helical, beta-sheet/beta-turn, 3 10 -helical, or pi-helical region within a peptide structure. The resulting peptides and methods of using them are also disclosed.

Claims (17)

1. A method of preparing a compound of Formula II:

wherein

R is hydrogen, an amino acid side chain, an alkyl group, or an aryl group;

R 1 is an amino acid side chain, an alkyl group, or an aryl group;

R 2 is an amino acid, peptide, OR, CH 2 NH 2 , an alkyl group, an aryl group, or a group of formula:

wherein R 7 is an amino acid, peptide, OR, CH 2 NH 2 , an alkyl group, or an aryl group; R 3 is an amino acid, peptide, OR, CH 9 Mi 2 , an alkyl group, an aryl group, hydrogen, or a group of formula

is a single or double carbon-carbon bond; is a single bond and is cis or trans when is a double bond; n is 1 or 2; and m is any number, said method comprising:

providing a compound of Formula I:

and

reacting said compound of Formula I under conditions effective to produce a compound of Formula II; wherein said reacting comprises a ring-closing metathesis reaction.

2. The method according to claim 1 , wherein said metathesis reaction is performed with a metathesis catalyst of the formula:

3. The method according to claim 2 , wherein said metathesis catalyst is of the formula:

4. The method according to claim 1 , wherein said metathesis reaction is performed at a temperature between about 25° C. and 110° C.

5. The method according to claim 1 , wherein said metathesis reaction is performed with an organic solvent.

6. The method according to claim 5 , wherein said organic solvent is selected from the group consisting of dichloromethane, dichloroethane, trichloroethane, and toluene.

7. The method according to claim 6 , wherein said organic solvent comprises dichloroethane.

8. The method according to claim 1 , wherein said reacting is carried out on a solid support.

Assignments (2)
EXECUTIVE ORDER 9424, CONFIRMATORY LICENSE Recorded May 9, 2008
From: NEW YORK UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 020928/0762 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 20, 2005
From: ARORA, PARAMJIT; CHAPMAN, ROSS
To: NEW YORK UNIVERSITY
Reel/Frame 017004/0777 →
Continuity (2)
Provisional Application 6057496400 · May 27, 2004
Related Publication 20060014675A1 · Jan 19, 2006